Cargando…
Hyperglycemia effect on coronary disease in patients with metabolic syndrome evaluated by intracoronary ultrasonography
INTRODUCTION: Metabolic syndrome (MS) is characterized by dyslipidemia, central obesity, hypertension and hyperglycemia. However, type 2 diabetes mellitus (T2DM) may or may not be present in metabolic syndrome. MS and T2DM are considered important cardiovascular risk factors, but the role of hypergl...
Autores principales: | Bonamichi, Beatriz Dal Santo Francisco, Parente, Erika Bezerra, Campos, Ana Carolina Noronha, Cury, Adriano Namo, Salles, João Eduardo Nunes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302811/ https://www.ncbi.nlm.nih.gov/pubmed/28187174 http://dx.doi.org/10.1371/journal.pone.0171733 |
Ejemplares similares
-
The influence of glycated hemoglobin in a study comparing patients who required hospitalization or not
por: Bonamichi, Beatriz Dal Santo Francisco, et al.
Publicado: (2015) -
MON-LB111 Evaluation of Mixed Meal Test on the Diagnosis of Hyperinsulinemic Hypoglycemia After Bariatric Surgery
por: Asato, Marilia Tomiyoshi, et al.
Publicado: (2020) -
Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs
por: Bonamichi, Beatriz Dal Santo Francisco, et al.
Publicado: (2017) -
COVID CORONARY: INTRACORONARY THROMBOLYTICS TO THE RESCUE
por: Randall, Morgan, et al.
Publicado: (2022) -
Editorial: Intracoronary Imaging Guidance for Percutaneous Coronary Interventions
por: Caiazzo, Gianluca, et al.
Publicado: (2022)